美股市场个股详情
AUTL Autolus Therapeutics
- 2.940
- +0.100+3.52%
收盘价 11/22 16:00 (美东)
- 2.910
- -0.030-1.02%
盘后 18:28 (美东)
7.82亿总市值-2409市盈率TTM
3.050最高价2.760最低价163.86万股成交量2.820今开2.840昨收484.70万成交额1.22%换手率亏损市盈率(静)2.66亿总股本7.45052周最高1.64市净率3.95亿流通值2.69052周最低--股息TTM1.34亿流通股53.240历史最高--股息率TTM10.20%振幅1.600历史最低2.958平均价1股每手
关于Autolus Therapeutics公司
Autolus Therapeutics PLC 是一家生物制药公司，致力于开发用于治疗癌症的下一代程序化 T 细胞疗法。 公司临床阶段管线包括Obe-cel（obecabtagene autoleucel）、AUTO1/22、AUTO3、AUTO5、AUTO6、AUTO7和AUTO8。
公司介绍
公司代码AUTL
公司名称Autolus Therapeutics
上市日期2018/06/22
发行价格17.00
成立日期2018
CEODr. Christian Itin, PhD.
所属市场纳斯达克
员工数量471
证券类型存托凭证
ADS转换比例1.0 : 1.0
年结日12-31
公司地址The Mediaworks,191 Wood Lane,White City
城市伦敦
省份大伦敦
国家英国
邮编W12 7FP
电话44-20-3829-6230
董事高管
- 姓名
- 职务
- 年薪
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 192.11万
- Martin Pule
- Senior Vice President and Chief Scientific Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Dr. Edgar Braendle
- Senior Vice President and Chief Development Officer
- --
- Alexander Swan
- Senior Vice President, Chief Human Resources Officer
- --
- Robert F. Dolski
- Senior Vice President, Chief Financial Officer
- --
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Michael W. Bonney
- Chairman of the Board
- --
- Robert W. Azelby
- Director
- --
- Dr. Ravi Madduri Rao
- Director
- --
- Dr. Elisabeth Leiderman, M.D.
- Director
- 1.27万
- Dr. Robert Iannone, M.D.
- Independent Director
- 13.49万
- John E. Berriman
- Independent Director
- 16.31万
- Dr. Joseph Anderson, PhD.
- Independent Director
- 19.56万
- Linda C. Bain
- Independent Director
- 16.95万
- William D. Young
- Independent Director
- 17.58万
- Dr. Martin Murphy, PhD
- Independent Director
- 15.83万
- Cynthia M. Butitta
- Independent Director
- 16.46万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据